Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05864586 · ClinicalTrials.gov registry record · NA
Developing E-liquid Product Standards (Sweet Spot Study)
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT05864586 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 150 participants.
The verdict
NCT05864586, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.
Interventions
- BEHAVIORAL Vaping study EC A
- BEHAVIORAL Vaping study EC B
- BEHAVIORAL Vaping study EC C
- BEHAVIORAL Vaping study EC D
- BEHAVIORAL Vaping study EC E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2024-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05864586
The ClinicalTrials.gov registry entry for NCT05864586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vaping study EC A is the first listed.
NCT05864586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05864586 about?
NCT05864586 is a clinical study titled "Developing E-liquid Product Standards (Sweet Spot Study)". The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.
What is the current status of trial NCT05864586?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2023-05-30. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT05864586?
The interventions under investigation include: Vaping study EC A (BEHAVIORAL), Vaping study EC B (BEHAVIORAL), Vaping study EC C (BEHAVIORAL), Vaping study EC D (BEHAVIORAL), Vaping study EC E (BEHAVIORAL).
Who is sponsoring clinical trial NCT05864586?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.